Dear ,
We’re excited to share this month’s progress and updates with you:
Preclinical Research Progress
Our Chief Medical Officer, Dr. Stanislav Žiaran, and Chief Bioengineer, Ján Kováč, have achieved significant milestones in our ongoing preclinical research:
Milestone 3: This critical milestone, focusing on tissue recellularization, is nearing completion. Biomechanical testing of the recellularized foreskins was successfully carried out this past weekend.
Milestone 4: The final milestone of this research project is set to begin next, with an anticipated completion timeline of 3–6 months. We will continue to keep you updated as this work advances toward clinical readiness.
Additionally, the initial setup has been completed and protocols developed for a timely histological analysis of the fully recellularized and maturized tissue. This brief analysis will be conducted following the completion of Milestone 4, providing the data needed to ensure the decellularization and recellularization protocols have been fully refined and perfected, in preparation for human clinical trials.
|
